rs281875199
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PS1_ModeratePM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_003070.5(SMARCA2):c.2554G>A(p.Glu852Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E852D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003070.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA2 | NM_003070.5 | c.2554G>A | p.Glu852Lys | missense_variant | 18/34 | ENST00000349721.8 | NP_003061.3 | |
SMARCA2 | NM_001289396.1 | c.2554G>A | p.Glu852Lys | missense_variant | 18/34 | NP_001276325.1 | ||
SMARCA2 | NM_139045.4 | c.2554G>A | p.Glu852Lys | missense_variant | 18/33 | NP_620614.2 | ||
SMARCA2 | NM_001289397.2 | c.2554G>A | p.Glu852Lys | missense_variant | 18/33 | NP_001276326.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA2 | ENST00000349721.8 | c.2554G>A | p.Glu852Lys | missense_variant | 18/34 | 5 | NM_003070.5 | ENSP00000265773.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 24, 2017 | The E852K variant in the SMARCA2 gene has been reported previously in two unrelated individuals with Nicolaides-Baraitser syndrome, for one individual the variant was paternally inherited and for the other individual the variant was de novo (Van Houdt et al., 2012; Wieczorek et al., 2013). The E852K variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The E852K variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret E852K as a pathogenic variant. - |
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Blepharophimosis-impaired intellectual development syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Developmental and Behavioral Pediatrics, First Affiliated Hospital of Jilin University | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at